| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |